US 10925971
Methods of treating PRLR positive breast cancer
granted A61KA61K2039/505A61K31/198
Quick answer
US patent 10925971 (Methods of treating PRLR positive breast cancer) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K2039/505, A61K31/198, A61K31/27, A61K31/565